메뉴 건너뛰기




Volumn 25, Issue 5, 2000, Pages 480-487

Comparison of 0.5% intrathecal bupivacaine with 0.5% intrathecal ropivacaine in the treatment of refractory cancer and noncancer pain conditions: Results from a prospective, crossover, double-blind, randomized study

Author keywords

Bupivacaine ropivacaine; Intrathecal; Refractory pain

Indexed keywords

BUPIVACAINE; ROPIVACAINE;

EID: 0033795133     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1053/rapm.2000.8574     Document Type: Article
Times cited : (35)

References (20)
  • 3
    • 0007775449 scopus 로고
    • Cross-over Trials in Clinical Research. Chichester, England: Wiley
    • (1993) , pp. 266
    • Senn, S.1
  • 7
    • 0027435706 scopus 로고
    • Increasing the reliability and validity of pain intensity measurement in chronic pain patients
    • (1993) Pain , vol.55 , pp. 195-203
    • Jensen, M.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.